Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ephraim J Fuchs

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Immunological Reviews|February 13, 2014
Transplantation tolerance: from theory to clinicEphraim J Fuchs
Current Opinion in Hematology|September 8, 2012
Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow graftsEphraim J Fuchs
Hematology. American Society of Hematology. Education Program|December 13, 2012
Haploidentical transplantation for hematologic malignancies: where do we stand?Ephraim J Fuchs
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2020
Does Post-Transplantation Cyclophosphamide Inhibit Graft-versus-Leukemia?Ephraim J Fuchs
Blood|April 11, 2015
Haplo graft engineering: sculpting to a TEphraim J Fuchs
Best Practice & Research. Clinical Haematology|November 23, 2015
Recent developments in HLA-haploidentical transplantationsMargaret Showel, Ephraim J Fuchs
Immunologic Research|January 13, 2010
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantationLeo Luznik, Ephraim J Fuchs
Seminars in Hematology|June 17, 2019
Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and resultsHany Elmariah, Ephraim J Fuchs
Cancer Control : Journal of the Moffitt Cancer Center|April 20, 2002
Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantationLeo Luznik, Ephraim J Fuchs
Current Opinion in Molecular Therapeutics|March 12, 2004
Hematopoietic stem cell transplant as a platform for tumor immunotherapyEphraim J Fuchs, Katharine A Whartenby
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Immunological Reviews|February 13, 2014
Transplantation tolerance: from theory to clinicEphraim J Fuchs
Current Opinion in Hematology|September 8, 2012
Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow graftsEphraim J Fuchs
Hematology. American Society of Hematology. Education Program|December 13, 2012
Haploidentical transplantation for hematologic malignancies: where do we stand?Ephraim J Fuchs
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2020
Does Post-Transplantation Cyclophosphamide Inhibit Graft-versus-Leukemia?Ephraim J Fuchs
Blood|April 11, 2015
Haplo graft engineering: sculpting to a TEphraim J Fuchs
Best Practice & Research. Clinical Haematology|November 23, 2015
Recent developments in HLA-haploidentical transplantationsMargaret Showel, Ephraim J Fuchs
Immunologic Research|January 13, 2010
High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantationLeo Luznik, Ephraim J Fuchs
Seminars in Hematology|June 17, 2019
Post-transplantation cyclophosphamide to facilitate HLA-haploidentical hematopoietic cell transplantation: Mechanisms and resultsHany Elmariah, Ephraim J Fuchs
Cancer Control : Journal of the Moffitt Cancer Center|April 20, 2002
Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantationLeo Luznik, Ephraim J Fuchs
Current Opinion in Molecular Therapeutics|March 12, 2004
Hematopoietic stem cell transplant as a platform for tumor immunotherapyEphraim J Fuchs, Katharine A Whartenby
Pageof 12